Engineered Cardiac Tissue with Biomimetic Architecture and Vasculature
Engineered Cardiac Tissue with Biomimetic Architecture and Vasculature
批准号:
9658550
负责人:
Christopher Kenji Arakawa
金额:
$5.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-03-16 至 2021-03-16
关键词:
3-DimensionalAccountingAction PotentialsAddressAnatomyArchitectureBiocompatible MaterialsBiomimeticsBlood VesselsBlood capillariesCalciumCaliberCardiacCardiac MyocytesCardiovascular DiseasesCardiovascular systemCell CommunicationCell DensityCell SurvivalCell physiologyCellsCellular MorphologyCessation of lifeCicatrixCoculture TechniquesComplexCouplingDepositionDevelopmentElectric StimulationEncapsulatedEndothelial CellsEndothelial Growth FactorsEndotheliumEngineeringEnvironmentExcisionExhibitsExtracellular MatrixGap JunctionsGelGenerationsGrowthHeartHeart DiseasesHeart failureHydrogelsIn VitroIndividualMatrix MetalloproteinasesMedicalMetabolicMethodologyModelingMuscle FibersMyocardial InfarctionMyocardial IschemiaMyocardial dysfunctionMyocardial tissueMyocardiumNatural regenerationNutrientParacrine CommunicationPathologicPatientsPatternPerfusionPeriodicityPolymersPrintingPropertyProtocols documentationPulsatile FlowRegenerative MedicineResearchResolutionRogaineShapesSourceStructureTechniquesTherapeuticThickTissue EngineeringTissuesTorsionUnited StatesVascularizationVentricularWorkbasecardiac regenerationcardiac repaircardiac tissue engineeringdensitydesignembryonic stem cellethylene glycolhealingheart dimension/sizeheart functionimprovedin vivointerestmortalitymulti-photonnoveloxygen transportphotolysisprogenitorregenerativestem cellstwo-photonvascular tissue engineeringwasting
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Ischemic heart disease accounts for approximately 42.5% of all cardiovascular-related deaths and afflicts
720,000 individuals/year. While current medical treatments have significantly decreased heart attack-
associated mortality, post-ischemic myocardial tissue undergoes pathologic remodeling and scarring,
subjecting patients to cardiac dysfunction and heart failure. As endogenous cardiac regeneration is limited,
stem cell and regenerative medicine-based approaches to cardiac repair represent promising solutions
towards regaining normal heart function. Bolstering interest in cardiovascular tissue engineering has given rise
to the development of novel biomaterials capable of maintaining cardiac cell function within a 3D tissue-like
environment, while detailed protocols have been developed to derive mature cardiomyocytes from a myriad of
stem cell sources; however, the essential ability to generate a construct that recapitulates the cellular
density and composition, thickness, and helicoid structure of the native heart has limited the therapeutic
applicability of tissue engineered constructs thus far. Utilizing photodegradable polymer-based hydrogels that
enable a spatially-defined co-culture of hES-derived cardiomyocytes and endothelial cells, we propose to
generate a densely-vascularized 3D cardiac construct exhibiting biomimetic helical tissue architecture. To
support the culture of a thick myocardial tissue and enhance mass transport of oxygen and nutrients, vessels
will be photopatterned into cell-laden hydrogels containing mature cardiomyocytes to generate perfusable
vasculature with similar size, shape, and structure to that of the native heart. Channels will be endothelialized
and perfused with fresh media using biomimetic pulsatile flow to encourage endothelial-cardiomyocyte cell
interaction. We aim to demonstrate that by controlling micron-scale channel architecture in a biomimetic
helical arrangement with near-native heart capillary density, paracrine signaling, ECM deposition, and direct
contact of endothelial cells and cardiomyocytes, we can direct cardiomyocyte orientation, enhance construct
contractility, and recapitulate the native torsional tissue contraction. As the proposed research will represent
the first successful strategy to generate perfusable vasculature networks with 3D features on the single-micron
scale, we expect that the developed methodologies will find wide applicability in the engineering of
vascularized constructs beyond cardiac tissue.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金